Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis

Overview of attention for article published in Frontiers in Pharmacology, June 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 11 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,193 followers.

RT @FrontPharmacol: New Research: Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cance…

22 Jun 2023

Reply Repost Favourite

New Research: Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis #pharmacology https://t.co/hGC8J3x3N3

22 Jun 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.